# The Tracking Molecular Evolution for NSCLC (T-MENC) Study

> **NCT03838588** · — · UNKNOWN · sponsor: **Geneplus-Beijing Co. Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Lung Neoplasms
- Lung Cancer
- Nonsmall Cell Lung Cancer
- Adenocarcinoma of Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03838588
- **Lead sponsor:** Geneplus-Beijing Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-06
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838588, "The Tracking Molecular Evolution for NSCLC (T-MENC) Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03838588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*